Casdin Capital, LLC Portfolio Holdings

Casdin Capital, LLC

  • $1.29 Billion
  • Q3 2024

Casdin Capital, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $1.29 Billion distributed in 35 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Biolife Solutions Inc with a value of $218M, Revolution Medicines, Inc. with a value of $186M, Standard Biotools Inc. with a value of $138M, Sarepta Therapeutics, Inc. with a value of $134M, and Illumina, Inc. with a value of $97.8M.

Examining the 13F form we can see an increase of $128M in the current position value, from $1.16B to 1.29B.

Casdin Capital, LLC is based out at New York, NY

Below you can find more details about Casdin Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $1.29 Billion
Healthcare: $1.29 Billion

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 35
  • Current Value $1.29 Billion
  • Prior Value $1.16 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 1 stocks
  • Additional Purchases 10 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 6 stocks
Track This Portfolio

Track Casdin Capital, LLC Portfolio

Follow Casdin Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Casdin Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email